Medico Remedies Ltd

Medico Remedies Ltd

Medico Remedies Ltd has announced the voting results of its 32nd Annual General Meeting (AGM), where all resolutions were passed with majority votes. The company has re-appointed Mr. Rishit Mehta as Whole-Time Director and Mr. Haresh Mehta as Chairman & Whole-Time Director. The remuneration of Mr. Harshit Mehta, Managing Director, and Ms. Priyal Rishit Mehta, Professional Consultant, has been increased.

Medico Remedies Ltd

Medico Remedies Ltd held its 32nd Annual General Meeting (AGM) on September 22, 2026, through video conferencing. The meeting was attended by 34 members, and the requisite quorum was present. The Chairman, Haresh Mehta, welcomed the members and presented an overview of the company's operations and financial performance during FY 2026. The meeting transacted ordinary and special business, including the re-appointment of directors and increases in remuneration.

Medico Remedies Ltd

Medico Remedies Ltd has submitted its Annual Report for the financial year 2025-26 along with the Notice of the 32nd Annual General Meeting. The meeting will be held on September 22, 2026, to consider the adoption of financial statements, appointment of a director, and re-appointment of Mr. Rishit Mehta as Whole-Time Director.

Medico Remedies Ltd

Medico Remedies Ltd has announced the book closure date for its 32nd Annual General Meeting, scheduled to take place on September 22, 2026.

Medico Remedies Ltd

Medico Remedies Ltd has submitted its annual report for the financial year 2025-26 and announced its 32nd Annual General Meeting (AGM) on September 22, 2026. The AGM will consider the adoption of financial statements, appointment of a director, and re-appointment of Mr. Rishit Mehta as Whole-Time Director.

Medico Remedies Ltd

Medico Remedies Ltd provided a clarification on the price movement of its shares, stating that there is no pending information or announcement required to be disclosed under SEBI (LODR) Regulations, 2015, and that the increase or decrease in share price is purely due to market conditions.

Medico Remedies Ltd

Medico Remedies Ltd has scheduled a Board Meeting on 13th August 2026 to consider and approve unaudited financial results for the quarter ended 30th June 2026, along with a limited review report.

Medico Remedies Ltd

Medico Remedies Ltd has secured a government supply order worth USD 1.4 million from PROMESE/CAL, Dominican Republic, to supply tablets, capsules, and dry syrups within 3 months.

Medico Remedies Ltd

The Bombay Stock Exchange (BSE) has sought clarification from Medico Remedies Ltd regarding significant price movement, to ensure investors have the latest relevant information.